Trial Profile
A phase IV, single centre, open-label study to investigate the kinetics of the B cell response to the first and the third immunization with Chiron meningococcal C conjugate vaccine administered to healthy infants at 2, 3 and 4 months of age
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2019
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine group C conjugate (Primary)
- Indications Meningococcal group C infections
- Focus Pharmacodynamics
- Sponsors Novartis
- 18 Sep 2014 New source identified and integrated (ClinicalTrials.gov : NCT00310700)
- 04 Nov 2006 New trial record.